The GLP-1 world is buzzing after Eli Lilly released a new weight loss pill. The Federal Food and Drug Administration approved the medication, called Foundayo, for market on April 1. Unlike most other ...

As the UAE becomes only the second country to approve the medication, experts explain why sustainable weight loss involves ...

Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth ...

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Federal regulators on Wednesday approved Eli Lilly’s new weight‑loss ...

The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections. By Dani Blum and Rebecca Robbins The Food and Drug Administration on Wednesday approved a ...

WASHINGTON — Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug ...

(Reuters) - Eli Lilly's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street ...

It was the '90s. Beauty standards were set by supermodels, and society's obsession with being thin birthed the hip-hugging low-rise jeans of Y2K. But often hiding behind the fashion glitz and glam ...